We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Podjanee Jittamala

Dr Podjanee Jittamala

Contact information

Email
Podjanee@tropmedres.ac

Research groups

MORU Mahidol Oxford Tropical Medicine Research Unit

Podjanee Jittamala

Senior Research Physician

A Senior Research Physician at MORU Medical Therapeutics Unit (MTU) and a paediatrician specialising in paediatric infectious diseases at the Faculty of Tropical Medicine, Mahidol University, Podjanee is an Assistant Professor in the Department of Tropical Hygiene. She works in the Hospital for Tropical Diseases and is also involved in teaching and research. Dr Podjanee’s research expertise includes infectious epidemiology and clinical trial i.e. malaria, dengue, HIV, tuberculosis, COVID 19 infection. She is also experienced in leading pragmatic trials, assessing the efficacy of treatments or therapies available for malaria in real-life routine practices.

Recent publications

Identification of the metabolites of ivermectin in humans

Tipthara P. et al, (2020)

Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials

Phommasone K. et al, (2020), PLOS ONE, 15, e0228190 - e0228190

The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial

von Seidlein L. et al, (2019), PLOS Medicine, 16, e1002745 - e1002745

RTS,S/AS01, a vaccine targeting pre-erythrocytic stages of Plasmodium falciparum.

von Seidlein L. et al, (2017), Emerging topics in life sciences, 1, 533 - 537

Pharmacokinetics of Orally Administered Oseltamivir in Healthy Obese and Nonobese Thai Subjects

Jittamala P. et al, (2014), Antimicrobial Agents and Chemotherapy, 58, 1615 - 1621